161 related articles for article (PubMed ID: 6987595)
1. [Present-day evaluation of allogeneic bone marrow transplantation].
Gluckman E
Pathol Biol (Paris); 1980 Jan; 28(1):5-7. PubMed ID: 6987595
[No Abstract] [Full Text] [Related]
2. [Treatment of selected nosological syndrome by means of bone marrow transplantation].
Kordecki H
Pol Tyg Lek; 1977 Mar; 32(10):415-7. PubMed ID: 320582
[No Abstract] [Full Text] [Related]
3. [Current views on allogenic bone marrow transportation].
Zupańska B
Acta Haematol Pol; 1978; 9(2):129-35. PubMed ID: 352083
[No Abstract] [Full Text] [Related]
4. [Allogeneic transplantation of HLA-compatible bone marrow. Initial results].
Jedrzejczak WW; Matej H; Szczylik C; Pojda Z; Ratajczak MZ; Myc A; Siekierzyński M; Kansy J; Kłos M; Rybicki Z
Pol Tyg Lek; 1988 Feb; 43(5):125-30. PubMed ID: 3043396
[No Abstract] [Full Text] [Related]
5. Second bone marrow transplant for children who relapsed or rejected their first graft: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP).
Miniero R; Busca A; Vai S; Locatelli F; Porta F; Messina C; Dini G; Arcese W; Amici A; Andolina M; Uderzo C; Di Bartolomeo P; Paolucci P; Pession A
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():135-8. PubMed ID: 8932815
[No Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplantation.
Tabbara IA
South Med J; 1996 Sep; 89(9):857-68. PubMed ID: 8790307
[TBL] [Abstract][Full Text] [Related]
7. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation.
Davies SM; Weisdorf DJ; Haake RJ; Kersey JH; McGlave PB; Ramsay NK; Blazar BR
Bone Marrow Transplant; 1994 Jul; 14(1):73-7. PubMed ID: 7951123
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation: acute and late complications.
Tabbara IA
Anticancer Res; 1996; 16(2):1019-26. PubMed ID: 8687093
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation in the treatment of human leukemia.
Krein BM
J Am Osteopath Assoc; 1978 Apr; 77(8):637-40. PubMed ID: 25857
[No Abstract] [Full Text] [Related]
10. Haploidentical bone marrow transplantation in leukemia and genetic diseases.
Andolina M; Maximova N; Rabusin M; Vujic D; Bunjevacki G; Vidali C; Beorchia A
Haematologica; 2000 Nov; 85(11 Suppl):37-40. PubMed ID: 11268322
[TBL] [Abstract][Full Text] [Related]
11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of CD34+ enriched allografts in children with nonmalignant diseases: does graft manipulation necessarily result in high incidence of graft failure?
Lang P; Handgretinger R; Greil J; Bader P; Schumm M; Klingebiel T; Niethammer D
Bone Marrow Transplant; 2004 Jan; 33(1):125-6; author reply 127. PubMed ID: 14647245
[No Abstract] [Full Text] [Related]
13. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
14. [Bone marrow transplantation. Experience of the Maisonneuve-Rosemont hospital center and insight concerning indications].
Perreault C; Gyger M; Bonny Y; Bélanger R; Boileau J; Tawil E; David M; Lacombe M; Lavallée R; D'Angelo G
Union Med Can; 1986 May; 115(5):295-302, 312. PubMed ID: 3532484
[No Abstract] [Full Text] [Related]
15. Early organ toxicity following allogeneic bone marrow transplantation in congenital hemopathies.
Di Bartolomeo P; Di Girolamo G; Olioso P; Bavaro P; Papalinetti G; Marsico S; Iacone A; Accorsi P; D'Antonio D; Angelone A; Papola F; Adorno D; Torlontano G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():152-6. PubMed ID: 8932819
[No Abstract] [Full Text] [Related]
16. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
17. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
[No Abstract] [Full Text] [Related]
18. [Treatment of acute bone-marrow suppression in an aseptic environment].
Blăha M; Mazák J; Vanásek J; Hrncír Z; Mĕrka V; Stroký O
Vnitr Lek; 1977 Aug; 23(8):769-72. PubMed ID: 333725
[No Abstract] [Full Text] [Related]
19. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for inherited diseases.
O'Marcaigh AS; Cowan MJ
Curr Opin Oncol; 1997 Mar; 9(2):126-30. PubMed ID: 9161789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
